These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8255914)

  • 1. Behavioral effects of the intraventricular administration of 5-HT and dopamine in the common marmoset (Callithrix jacchus).
    Oliveira Mda P; Campos Mde F
    Pharmacol Biochem Behav; 1993 Sep; 46(1):21-5. PubMed ID: 8255914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rats and marmosets respond differently to serotonin agonists and antagonists.
    Campos MF; Rodrigues F das C
    Psychopharmacology (Berl); 1987; 92(4):478-83. PubMed ID: 3114802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.
    Kostrzewa RM; Brus R; Perry KW; Fuller RW
    Acta Neurobiol Exp (Wars); 1996; 56(1):21-8. PubMed ID: 8787176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of 5-hydroxytryptamine and dopamine neurones in the behavioural effects of alpha-methylytryptamine.
    Marsden CA
    Neuropharmacology; 1980 Aug; 19(8):691-8. PubMed ID: 6448356
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural pharmacology of dopamine, serotonin and putative aminergic ligands in the mushroom bodies of the honeybee (Apis mellifera).
    Blenau W; Erber J
    Behav Brain Res; 1998 Nov; 96(1-2):115-24. PubMed ID: 9821548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of dopamine and 5-hydroxytryptamine in centrally chemosympathectomized rats.
    Herman ZS; Brus R; Szkilnik R
    Pol J Pharmacol Pharm; 1976; 28(5):463-7. PubMed ID: 1012976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Dupre KB; Eskow KL; Negron G; Bishop C
    Brain Res; 2007 Jul; 1158():135-43. PubMed ID: 17553470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study.
    Bonhomme N; Cador M; Stinus L; Le Moal M; Spampinato U
    Brain Res; 1995 Mar; 675(1-2):215-23. PubMed ID: 7796132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.
    Uchida S; Soshiroda K; Okita E; Kawai-Uchida M; Mori A; Jenner P; Kanda T
    Eur J Pharmacol; 2015 Nov; 766():25-30. PubMed ID: 26415982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.